Vox Markets Logo
5th November 2024
14:25

Nuformix PLC - Director/PDMR Dealings

4th November 2024
10:17

Nuformix PLC - Result of General Meeting

16th October 2024
12:37

Nuformix PLC - Publication of Prospectus & Notice of GM

20th September 2024
13:24

Nuformix PLC - £300,000 Fundraise

18th June 2024
06:00

Nuformix PLC - Half-year Report

17th June 2024
06:00

Nuformix PLC - Patent Update

19th March 2024
14:39

Nuformix PLC - Result of AGM

1st March 2024
07:00

Nuformix PLC - Subscription to raise £150,000

15th January 2024
11:30

Nuformix PLC - Posting of Annual Report and Notice of AGM

3rd January 2024
07:00

Nuformix PLC - Results for the period ended 30 September 2023

18th December 2023
07:00

Nuformix PLC - NXP001 Update

23rd October 2023
06:00

Nuformix PLC - Notice of Allowance of NXP002 Patent in Japan

18th September 2023
06:00

Nuformix PLC - NXP001 Update

24th August 2023
12:22

Nuformix PLC - Result of Annual General Meeting

31st July 2023
13:00

Nuformix PLC - Notice of AGM

26th July 2023
13:55

Nuformix PLC - Holding(s) in Company

2nd June 2023
06:00

Nuformix PLC - Investor Online Q&A

25th May 2023
06:00

Nuformix PLC - Change of Auditor

22nd May 2023
06:00

Nuformix PLC - Unaudited Interim Report

Nuformix plc (NFX.L) Share Price & News


Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -M
  • LOW
    -
  • CLOSE
    -
  • SHARES IN ISSUE
    744.31M

Nuformix plc Company Profile

Nuformix is a pharmaceutical development company using cocrystal technology, unlocking the therapeutic potential of approved drugs with lead programmes in oncology supportive care and fibrosis.

Featured Media

Watchlist